Homestead Advisers Corp Adma Biologics, Inc. Transaction History
Homestead Advisers Corp
- $3.96 Billion
- Q3 2025
A detailed history of Homestead Advisers Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Homestead Advisers Corp holds 198,500 shares of ADMA stock, worth $3.09 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
198,500
Previous 108,400
83.12%
Holding current value
$3.09 Million
Previous $1.97 Million
47.49%
% of portfolio
0.07%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
406Shares Held
202MCall Options Held
3.06MPut Options Held
1.88M-
Vanguard Group Inc Valley Forge, PA21MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$290 Million0.0% of portfolio
-
State Street Corp Boston, MA13.6MShares$211 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.5MShares$195 Million0.03% of portfolio
-
Sachem Head Capital Management LP New York, NY8.96MShares$139 Million5.63% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.06B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...